In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Respirics Inc.

Latest From Respirics Inc.

Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q2 2007

In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmaking-for April-June 2007. Our data are derived from Windhover's Strategic Transactions Database.

BioPharmaceutical Medical Device

Deals Update (05/2007)

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Medical Device

Emergings in Brief (1/02)

Start-Up showcases the following recently launched companies: Molecular Nanosystems Inc., Protea Biosciences Inc., Respirics Inc. and U3 Pharma AG.

Selected Start-Ups (12/01)

In Vivo briefly summarizes the technologies of these recently founded companies: KetoCytonyx Inc., KMT Hepatech Inc., Nanosys Inc., Respirics Inc., Scion Pharmaceuticals Inc. and Somatocor Inc.

See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary